guia_fractura_cadera

FRACTURA DE CADERA. Anciano afecto de fractura de cadera
27. Zahn HR, Skinner JA, Porteous MJ. The preoperative prevalence of deep vein thrombosis in
patients with femoral neck fractures and delayed operation. Injury. 1999;30:605-7.
28. Pace NL. Anesthetic techniques during surgical repair of femoral nec fractures: a meta-analysis.
Anesthesiology. 1992;77:1095-104.
29. Sevitt S, Gallagher NG. Prevention of venous thrombosis and pulmonary embolism in injured
patients: a trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly
patients with fractured necks of femur. Lancet. 1959;2:981-9.
30. Tapson VF, Hyers TM, Waldo AL, Ballard DJ, Becker RC, Caprini JA, et al; NABOR (National
Anticoagulation Benchmark and Outcomes Report) Steering Committee. Antithrombotic
therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med.
2005;165:1458-64.
31. Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH. A meta-analysis of
thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am.
2000;82-A:929-38.
32. Handoll HHG, Farrar MJ, McBirnie J, Tytherleigh-Strong G, Milne AA, Gillespie WJ. Heparin,
low molecular weight heparin and physical methods for preventing deep vein thrombosis and
pulmonary embolism following surgery for hip fractures. The Cochrane Database of
Systematic Reviews 2002. Issue 4. Art. No. CD000305.
33. Palmer AJ, Koppenhagen K, Kirchof B, Weber U, Bergemann R. Efficacy and safety of low molecular
weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in
orthopaedic surgery: a meta-analysis of randomised clinical trials. Haemostasis. 1997;27:75-84.
34. Navarro-Quilis A, Castellet E, Rocha E, Paz-Jiménez J, Planès A. Efficacy and safety of Bemiparin
compared with Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty.
A randomized double-blind clinical trial. J Thromb Haemost. 2003;1:425-32.
35. Abad JI, Gomez-Outes A, Martinez-Gonzalez J, Rocha E; on behalf of the Bemiparin 6 Hours
After Surgery Study Group. A prospective observational study on the effectiveness and safety of
bemiparin, first dose administered 6 h after knee or hip replacement surgery. Arch Orthop
Trauma Surg. 2006; DOI: 10.1007/s00402-006-0239-x.
36. Planes A. Review on bemiparibn sodium –a new second generation low-molecular-weight
heparin– and its applications in venous thromboembolism. Expert Opin Pharmacother.
2003;4:1551-61.
37. Monreal M, Lafoz E, Navarro A, et al. A prospective double-blind trial of a low molecular
weight heparin once daily compared with conventional low-dose heparin three times daily to
prevent pulmonary embolism and venous thrombosis in patients with hip fracture. J Trauma.
1989;29,873-5.
38. Nurmohamed MT, Rosendaal FR, Büller HR, et al. Low Molecular Weight heparin in the
prophylaxis of venous thrombosis: a meta-analisis. Lancet. 1992;340:152.
39. Díaz Díaz JL. Enfermedad tromboembólica venosa. Revisiones en Medicina Interna Basadas
en la Evidencia. Disponible en: www.meiga.info/mbe/ETV.pdf
40. Powers PJ, Gent M, Jay RM, et al. A randomized trial of less intense postoperative warfarin
or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured
hip. Arch Intern Med. 1989;149,771-4.
127